公司资料
Alterity Therapeutics 股价、新闻与催化剂
- 股票代码:
- ATHE
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Australia and listed in the U
股票表现
3.75 USD (-2.60%)
收盘价
最后更新: 2026年9月17日
1.46M USD
市值
股价为何变动
截至 2026年9月17日，ATHE 下跌 2.60%，收于 $3.75。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Alterity Therapeutics is a neuroscience company focused on neurodegenerative disease, especially disorders with alpha-synuclein pathology. Its story is built around trying to address difficult CNS diseases through disease-modifying biology.
所在地与行业分类
Alterity is headquartered in Australia and listed in the U.S. market. It sits in small-cap neuroscience biotechnology.
商业模式特征
The company depends on translational validation, clinical progress, and capital support. Investors usually watch early data and whether the biology can create a compelling neurodegeneration thesis.
生物医药行业定位
Alterity occupies a specialized neurodegeneration niche within biotech. It is catalyst-sensitive because the market needs evidence that the platform can matter in CNS disease.
未来催化剂
- Alterity’s catalysts are ATH434 and the neurodegeneration / iron-biology story, with any clinical update that can re-rate the name quickly. The company is still very much a proof-of-concept story.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。